Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Gross Profit: 2016-2025

Historic Gross Profit for Collegium Pharmaceutical (COLL) over the last 9 years, with Sep 2025 value amounting to $129.2 million.

  • Collegium Pharmaceutical's Gross Profit rose 33.45% to $129.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $433.2 million, marking a year-over-year increase of 15.92%. This contributed to the annual value of $377.3 million for FY2024, which is 15.69% up from last year.
  • Collegium Pharmaceutical's Gross Profit amounted to $129.2 million in Q3 2025, which was up 19.18% from $108.4 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Gross Profit registered a high of $129.2 million during Q3 2025, and its lowest value of -$1.3 million during Q4 2021.
  • Its 3-year average for Gross Profit is $94.4 million, with a median of $94.6 million in 2023.
  • Per our database at Business Quant, Collegium Pharmaceutical's Gross Profit crashed by 103.01% in 2021 and then soared by 3,835.11% in 2022.
  • Collegium Pharmaceutical's Gross Profit (Quarterly) stood at -$1.3 million in 2021, then spiked by 3,835.11% to $49.8 million in 2022, then spiked by 90.06% to $94.6 million in 2023, then increased by 3.87% to $98.3 million in 2024, then soared by 33.45% to $129.2 million in 2025.
  • Its Gross Profit stands at $129.2 million for Q3 2025, versus $108.4 million for Q2 2025 and $97.3 million for Q1 2025.